Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is widely used in the management of HIV-infection, but has been associated with renal impairment in a small proportion of patients. Tenofovir alafenamide (TAF), a novel prodrug of tenofovir, causes less renal impairment and can improve renal function i...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Dane, Drak, Douglas, O’Connor, Catherine C., Templeton, David J., Gracey, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898922/
https://www.ncbi.nlm.nih.gov/pubmed/31810490
http://dx.doi.org/10.1186/s12981-019-0256-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898922/
https://www.ncbi.nlm.nih.gov/pubmed/31810490
http://dx.doi.org/10.1186/s12981-019-0256-9

Ejemplares similares